Haleon plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HLN research report →
About the company
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements.
- CEO
- Brian James McNamara
- IPO
- 2022
- Employees
- 24,561
- HQ
- Weybridge, GB
Price Chart
- Market Cap
- $40.22B
- P/E
- 29.53
- P/S
- 3.63
- P/B
- 1.86
- EV/EBITDA
- 17.93
- Div Yield
- 2.10%
- Gross Margin
- 61.45%
- Op Margin
- 18.85%
- Net Margin
- 12.59%
- ROE
- 6.43%
- ROIC
- 4.13%
- Revenue
- $10.79B · -3.96%
- Net Income
- $1.63B · 13.07%
- EPS
- $0.36 · 12.50%
- Op Income
- $2.42B
- FCF YoY
- -3.91%
- 52W High
- $11.28
- 52W Low
- $8.65
- 50D MA
- $9.40
- 200D MA
- $9.74
- Beta
- 0.25
- Avg Volume
- 8.50M
Get TickerSpark's AI analysis on HLN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HLN coverage
Recent articles, reports, and earnings notes.
No research on HLN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HLN report →Similar companies
Peers in the same neighborhood.